Navigating Nebulized LAMAs for COPD Patients

Guest: Farrukh Abbas, MD

On average, more than two-thirds of patients with chronic obstructive pulmonary disease (COPD) make at least one error in using an inhaler device. Fortunately, nebulized long-acting muscarinic antagonists (LAMAs) can help our patients overcome this common challenge in COPD care. That’s why Drs. Megan Conroy and Farrukh Abbas come together to talk about the GOLD treatment guidelines, strategies for reducing patient hesitancy regarding nebulized LAMAs, and more.

This episode is produced in partnership with the American College of CHEST Physicians and is sponsored by Viatris Inc.